Systematic analysis of early phase clinical studies for patients with breast cancer: Inclusion of patients with brain metastasis

Most published early phase clinical trials either did not clearly document or did not allow for accrual of patients with CNS disease. Early phase trials with targeted agents or enrolling HER2+ MBC had higher odds of permitting CNS metastases.